In recognition of World Dense Breast Day on September 25, Bayer has announced a new study, published in Patient Preference and Adherence, that explores gaps in awareness and knowledge of breast cancer risk factors (BCRFs) among women with and without…
As British Columbians head to the polls on October 19, the Gastrointestinal Society is drawing attention to a critical issue: BC PharmaCare’s refusal to fund over 30 essential medications that are covered in most other provinces. This gap in coverage…
Omnicell, Inc. (Nasdaq: OMCL), a leader in transforming pharmacy care delivery, has announced the appointment of Nnamdi Njoku as Executive Vice President and Chief Operating Officer, effective October 7, 2024. In this newly created role, Njoku will report directly to…
a leading precision medicine company utilizing artificial intelligence (AI) to enhance cancer treatment, has announced its expansion into human oncology. Building on its successful work in veterinary oncology, ImpriMed will now offer precision medicine services for human blood cancers, including…
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) has announced the appointment of Catherine Owen Adams as its new Chief Executive Officer (CEO), succeeding Steve Davis. Adams will also join the company’s Board of Directors. “We are thrilled to welcome Catherine Owen Adams…
Aditxt, Inc. (NASDAQ: ADTX), an innovation-driven company focused on accelerating healthcare advancements, announced today that its majority-owned subsidiary, Pearsanta, Inc., has entered into a Market Development Collaboration Agreement with Evofem Biosciences, Inc. (OTCQB: EVFM), a leader in women’s health. This…
Negotiations on the world’s first agreement to safeguard people from future pandemics, led by the World Health Organization (WHO), made significant strides during the latest round of discussions, which concluded today. Key achievements of the 11th meeting of the Intergovernmental…
Samsung Bioepis Co., Ltd. and Biogen Inc. (Nasdaq: BIIB) have announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for OPUVIZ™ 40 mg/mL solution for injection in a vial,…
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) have received a recommendation for marketing authorization from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) for their Omicron KP.2-adapted monovalent COVID-19 vaccine (COMIRNATY®…
Merck (NYSE: MRK), known as MSD outside the U.S. and Canada, announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued positive opinions recommending the approval of KEYTRUDA® (pembrolizumab) for two gynecologic cancer indications.…
The Family Heart Foundation, a prominent research and advocacy organization, has announced the successful completion of its Flag, Identify, Network, and Deliver™ “FIND Lp(a)” machine learning model. This groundbreaking tool is now being implemented in healthcare systems across the United…
Organon (NYSE: OGN), a global healthcare company dedicated to improving women’s health, has announced a definitive agreement to acquire Dermavant Sciences, a subsidiary of Roivant (NASDAQ: ROIV). Dermavant specializes in developing innovative therapies for immuno-dermatology. The acquisition includes VTAMA® (tapinarof)…
